by Peter Jones, PhD, and Takako Jones, PhD, University of Nevada, Reno The aberrant expression of the DUX4 primate retrotransposon is the key mediator of all forms of FSHD. Thus,… Read More »
A tunable FSHD-like DUX4 mouse model
On patient registries: findings from our suvey
Last November, the FSH Society invited its members to participate in a survey designed to gauge what members understand about patient registries and for researchers to gain insight into what kind of… Read More »
Acceleron adds 2 new sites for ACE-083 clinical trial
Cambridge, Massachusetts-based Acceleron Pharma, Inc., is now recruiting adults with FSH muscular dystrophy for a Phase 2 clinical trial of ACE-083 at sites in Kansas City, KS, and Rochester, NY,… Read More »
Global FSHD Registry Workshop
International workshop in November reaches consensus on a global FSHD patient registry. If you are an individual with FSHD, or a family member, you may have been asked to join a… Read More »
FSHD imaging study is recruiting volunteers
The Kennedy Krieger Institute is recruiting volunteers with FSHD for a clinical research study. Volunteers will be asked to undergo muscle strength testing and non-invasive magnetic resonance imaging (MRI) and… Read More »